OCLN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.488400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.635600E-01
Normal-vs-Stage2
6.581400E-01
Normal-vs-Stage3
6.645000E-01
Normal-vs-Stage4
3.871200E-01
Stage1-vs-Stage2
8.204200E-01
Stage1-vs-Stage3
2.994800E-01
Stage1-vs-Stage4
4.410000E-01
Stage2-vs-Stage3
2.363000E-01
Stage2-vs-Stage4
1.451010E-01
Stage3-vs-Stage4
1.652170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.950400E-01
Normal-vs-AfricanAmerican
4.284400E-01
Normal-vs-Asian
7.096000E-01
Caucasian-vs-AfricanAmerican
2.286800E-01
Caucasian-vs-Asian
7.780000E-01
AfricanAmerican-vs-Asian
4.130400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.474000E-01
Normal-vs-Female
9.090600E-01
Male-vs-Female
1.399200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.485000E-01
Normal-vs-Age(41-60Yrs)
6.139800E-01
Normal-vs-Age(61-80Yrs)
8.261000E-01
Normal-vs-Age(81-100Yrs)
8.879200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.287000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.323000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.065200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.766000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.207000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.184200E-01
Normal-vs-Daily Drinker
8.960400E-01
Normal-vs-Weekly Drinker
9.239800E-01
Normal-vs-Occasional Drinker
5.610600E-01
Normal-vs-Social Drinker
8.490800E-01
Non Drinker-vs-Daily Drinker
9.395200E-01
Non Drinker-vs-Weekly Drinker
5.318400E-01
Non Drinker-vs-Occasional Drinker
3.197800E-01
Non Drinker-vs-Social Drinker
4.079400E-01
Daily Drinker-vs-Weekly Drinker
6.830200E-01
Daily Drinker-vs-Occasional Drinker
4.127800E-01
Daily Drinker-vs-Social Drinker
5.526800E-01
Weekly Drinker-vs-Occasional Drinker
2.219400E-01
Weekly Drinker-vs-Social Drinker
9.397400E-01
Occasional Drinker-vs-Social Drinker
1.187380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.784400E-02
Normal-vs-Grade 2
2.644300E-02
Normal-vs-Grade 3
1.318120E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.003770E-01
Grade 1-vs-Grade 3
4.105900E-02
Grade 1-vs-Grade 4
8.784400E-02
Grade 2-vs-Grade 3
4.995600E-01
Grade 2-vs-Grade 4
2.644300E-02
Grade 3-vs-Grade 4
1.318120E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.868600E-01
Normal-vs-NonDiabetic
7.352400E-01
Diabetic-vs-NonDiabetic
2.681000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.895000E-01
Normal-vs-NoPancreatitis
7.722800E-01
Pancreatitis-vs-NoPancreatitis
5.513200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.769600E-01
Normal-vs-N1
6.769800E-01
N0-vs-N1
3.427000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.485200E-01
Normal-vs-TP53-NonMutant
6.181200E-01
TP53-Mutant-vs-TP53-NonMutant
2.784400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
